Pascal and Francis Bibliographic Databases

Help

Search results

Your search

kw.\*:("Non-small cell lung cancer (NSCLC)")

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 79

  • Page / 4
Export

Selection :

  • and

Emerging role of epidermal growth factor receptor inhibition in therapy for advanced malignancy: Focus on NSCLCLANGER, Corey J.International journal of radiation oncology, biology, physics. 2004, Vol 58, Num 3, pp 991-1002, issn 0360-3016, 12 p.Conference Paper

Lung tumor segmentation in PET images using graph cutsBALLANGAN, Cherry; XIUYING WANG; FULHAM, Michael et al.Computer methods and programs in biomedicine (Print). 2013, Vol 109, Num 3, pp 260-268, issn 0169-2607, 9 p.Article

Activity-based proteomics: Identification of ABHD11 and ESD activities as potential biomarkers for human lung adenocarcinomaWIEDL, T; ARNI, S; ROSCHITZKI, B et al.Journal of proteomics (Print). 2011, Vol 74, Num 10, pp 1884-1894, issn 1874-3919, 11 p.Article

Gefitinib ('Iressa'): a new therapy for advanced non-small-cell lung cancerRECK, Martin; GATZEMEIER, Ulrich.Respiratory medicine. 2005, Vol 99, Num 3, pp 298-307, issn 0954-6111, 10 p.Article

Molecular prognostic factors in resectable non-small cell lung cancerVIELH, P; SPANO, J.-P; GRENIER, J et al.Critical reviews in oncology/hematology. 2005, Vol 53, Num 3, pp 193-197, issn 1040-8428, 5 p.Article

Detection of epidermal growth factor receptor (EGFR) mutations in non-small cell lung cancer (NSCLC) using a fully automated system with a nano-scale engineered biomagnetiteMARUYAMA, Kohei; TAKEYAMA, Haruko; MORI, Tetsushi et al.Biosensors & bioelectronics. 2007, Vol 22, Num 9-10, pp 2282-2288, issn 0956-5663, 7 p.Conference Paper

Correlation between interleukin 6 production and tumor proliferation in non-small cell lung cancerYAMAJI, Haruko; IIZASA, Toshihiko; NAKAYAMA, Toshinori et al.Cancer immunology and immunotherapy. 2004, Vol 53, Num 9, pp 786-792, issn 0340-7004, 7 p.Article

Rationale of a relaunch of gefitinib in Caucasian non-small cell lung cancer patientsPIRCHER, Andreas; PLONER, Ferdinand; POPPER, Helmut et al.Lung cancer. 2010, Vol 69, Num 3, pp 265-271, issn 0169-5002, 7 p.Article

Compensation of type I and type II cytokeratin pools in lung cancerKANAJI, Nobuhiro; BANDOH, Shuji; FUJITA, Jiro et al.Lung cancer. 2007, Vol 55, Num 3, pp 295-302, issn 0169-5002, 8 p.Article

Glutathione S-transferase PI (GST-PI) mRNA expression and DNA methylation is involved in the pathogenesis and prognosis of NSCLCGRIMMINGER, Peter P; MAUS, Martin K. H; SCHNEIDER, Paul M et al.Lung cancer. 2012, Vol 78, Num 1, pp 87-91, issn 0169-5002, 5 p.Article

Immune activation status of CD8+ T cells infiltrating non-small cell lung cancerTROJAN, Andreas; UROSEVIC, Mirjana; DUMMER, Reinhard et al.Lung cancer. 2004, Vol 44, Num 2, pp 143-147, issn 0169-5002, 5 p.Article

Prognostic potential of FOXP3 expression in non-small cell lung cancer cells combined with tumor-infiltrating regulatory T cellsTAO, Hiroyuki; MIMURA, Yusuke; AOE, Keisuke et al.Lung cancer. 2012, Vol 75, Num 1, pp 95-101, issn 0169-5002, 7 p.Article

The identification of KRAS mutations at codon 12 in plasma DNA is not a prognostic factor in advanced non-small cell lung cancer patientsCAMPS, Carlos; JANTUS-LEWINTRE, Eloisa; SIRERA, Rafael et al.Lung cancer. 2011, Vol 72, Num 3, pp 365-369, issn 0169-5002, 5 p.Article

Expression of Bcl-2 predicts outcome in locally advanced non-small cell lung cancer patients treated with cisplatin-based concurrent chemoradiotherapySEONG HYUN JEONG; JAE HO JUNG; YOUNG TAEK OH et al.Lung cancer. 2010, Vol 68, Num 2, pp 288-294, issn 0169-5002, 7 p.Article

Phosphodiesterase inhibitors as anti-cancer drugsHIRSH, Liron; DANTES, Ada; SUH, Byong-Sun et al.Biochemical pharmacology. 2004, Vol 68, Num 6, pp 981-988, issn 0006-2952, 8 p.Article

IMPACT OF INCIDENTAL IRRADIATION ON CLINICALLY UNINVOLVED NODAL REGIONS IN PATIENTS WITH ADVANCED NON-SMALL-CELL LUNG CANCER TREATED WITH INVOLVED-FIELD RADIATION THERAPY: DOES INCIDENTAL IRRADIATION CONTRIBUTE TO THE LOW INCIDENCE OF ELECTIVE NODAL FAILURE?KIMURA, Tomoki; TOGAMI, Taro; NISHIYAMA, Yoshihiro et al.International journal of radiation oncology, biology, physics. 2010, Vol 77, Num 2, pp 337-343, issn 0360-3016, 7 p.Article

Accuracy and prognostic impact of a vessel invasion grading system for stage IA non-small cell lung cancerHASHIZUME, Satoshi; NAGAYASU, Takeshi; HAYASHI, Tomayoshi et al.Lung cancer. 2009, Vol 65, Num 3, pp 363-370, issn 0169-5002, 8 p.Article

The role of CD133 in the identification and characterisation of tumour-initiating cells in non-small-cell lung cancerTIRINO, Virginia; CAMERLINGO, Rosa; FRANCO, Renato et al.European journal of cardio-thoracic surgery. 2009, Vol 36, Num 3, pp 446-453, issn 1010-7940, 8 p.Conference Paper

IL-2, TNF-α, and leptin : Local versus systemic concentrations in NSCLC patientsCARPAGNANO, Giovanna E; SPANEVELLO, Antonio; CURCI, Claudia et al.Oncology research. 2007, Vol 16, Num 8, pp 375-381, issn 0965-0407, 7 p.Article

A phase II trial of vinorelbine plus gemcitabine in previously untreated inoperable (stage IIIb/IV) non-small-cell lung cancer patients aged 80 or olderCHEN, Yuh-Min; PERNG, Reury-Perng; CHEN, Mei-Chun et al.Lung cancer. 2003, Vol 40, Num 2, pp 221-226, issn 0169-5002, 6 p.Article

Prognostic significance of osteopontin expression in early-stage non-small-cell lung cancerBOLDRINI, L; DONATI, V; FONTANINI, G et al.British journal of cancer. 2005, Vol 93, Num 4, pp 453-457, issn 0007-0920, 5 p.Article

Gefitinib as a last treatment option for non-small-cell lung cancer: durable disease control in a subset of patientsHARINGHUIZEN, A; VAN TINTEREN, H; VAESSEN, H. F. R et al.Annals of oncology. 2004, Vol 15, Num 5, pp 786-792, issn 0923-7534, 7 p.Article

CT-guided interstitial brachytherapy of inoperable non-small cell lung cancerWANG, Zhong-Min; JIAN LU; TAO LIU et al.Lung cancer. 2011, Vol 74, Num 2, pp 253-257, issn 0169-5002, 5 p.Article

Serum tenascin-C as a potential predictive marker of angiogenesis in non-small cell lung cancerISHIWATA, Toshiji; TAKAHASHI, Kazuhisa; SHIMANUKI, Yuri et al.Anticancer research. 2005, Vol 25, Num 1B, pp 489-495, issn 0250-7005, 7 p.Article

Phase I/II study of cisplatin combined with weekly paclitaxel in patients with advanced non-small-cell lung cancerYOSHIMURA, N; KUDOH, S; MUKOHARA, T et al.British journal of cancer. 2004, Vol 90, Num 6, pp 1184-1189, issn 0007-0920, 6 p.Article

  • Page / 4